蛋白激酶B
磷酸化
化学
细胞生物学
PI3K/AKT/mTOR通路
癌症研究
癌细胞
生物
信号转导
癌症
生物化学
遗传学
作者
Guanlan Fan,Fan Wang,Yurou Chen,Qian Zheng,Jie Xiong,Qiongying Lv,Kejia Wu,Jiaqiang Xiong,Lei Wei,Dongqing Li,Jiachen Zhang,Wei Zhang,Feng Li
出处
期刊:Cell Reports
[Cell Press]
日期:2022-12-28
卷期号:42 (1): 111916-111916
被引量:16
标识
DOI:10.1016/j.celrep.2022.111916
摘要
Akt is commonly activated and serves as a valuable target in human cancer. In this study, OTUD1 is identified as an Akt-associated protein and is downregulated upon Akt activation. Ectopic OTUD1 inhibits Akt phosphorylation; however, its deubiquitinase activity contributes only slightly to this effect. A short peptide (OUN-36) located in the OTUD1 N-terminal intrinsically disordered region strongly binds to the Akt PH domain. The residues in the PH domain, which are required for PtdIns(3,4,5)P3 recognition, are also essential for OUN-36 binding. OUN-36 preferentially inhibits Akt-hyperactive tumor cells' proliferation and interferes with Akt cell membrane localization, presumably by disrupting PH domain-PIP3 interaction. Importantly, OUN-36-based therapy efficiently abrogates Akt feedback reactivation in response to MK-2206 treatment and sensitizes cancer cells to chemotherapy and immunotherapy. We therefore show a mechanism by which OTUD1 modulates Akt activity and suggest a potential peptide-based cancer therapeutic strategy implemented by targeting the Akt PH domain.
科研通智能强力驱动
Strongly Powered by AbleSci AI